葡萄糖皮质体受体信号传递:复杂性和治疗机会
Dorien Clarisse1, Laura Van Moortel1, Chloé Van Leene1
1VIB Center for Medical Biotechnology, Ghent, Belgium; Department of Biomolecular Medicine, Ghent University, Ghent, Belgium; Cancer Research Institute Ghent, Ghent, Belgium.
探索葡萄糖皮质体受体 (GR),一个关键的药物标,揭示了其机制的洞察力. 了解GR域通信和染色质相互作用可以带来更好的疗法,副作用更少.
科学领域:
- 分子生物学分子生物学
- 内分泌学 在内分泌学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 葡萄糖皮质体受体 (GR) 是一个关键的核受体 (NR),用于治疗炎症和癌症.
- 当前的GR配体虽然有效,但由于系统性作用导致显著的副作用,限制了它们的治疗应用.
研究的目的:
- 探索对GR作用机制的新概念和见解,以提高治疗效益.
- 确定开发改进GR向疗法的策略,并减少副作用.
主要方法:
- 分析不同GR域之间的通信以及各种连接体的影响.
- 研究GR与染色质的相互作用,包括凝结物形成和核心调节器限制的作用.
- 探索新型连接体潜力和治疗利用与其他核受体的交叉通话.
主要成果:
- 详细的发现是关于GR域之间的联体特异通信.
- 演示GR-染色素相互作用,凝聚物形成和核心调节器限制如何影响转录反应.
- 在治疗策略中识别新联体和NR交叉的潜力.
结论:
- 了解GR的复杂机制,包括域通信和色素相互作用,对于开发更安全,更有效的疗法至关重要.
- 新型配体和向NR交叉对炎症性疾病和癌症的基于GR的改善治疗提供了有希望的途径.
更多相关视频
07:41A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators
Published on: February 20, 2018
06:56A Flow Cytometry-based Assay to Identify Compounds That Disrupt Binding of Fluorescently-labeled CXC Chemokine Ligand 12 to CXC Chemokine Receptor 4
Published on: March 10, 2018
相关概念视频
Signal Transduction: Overview
Typically, signal transduction involves three...
Insulin: The Receptor and Signaling Pathways
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
The JAK-STAT Signaling Pathway
GPCR Desensitization
